Crescent Biopharma, Inc. (CBIO) vs Tactile Systems Technology, Inc. (TCMD)
A side-by-side comparison of Crescent Biopharma, Inc. and Tactile Systems Technology, Inc. across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of October 6, 2026. Differences are shown without an overall score or investment verdict.
CBIO
Crescent Biopharma, Inc.
$13.57HealthcareDelayed quote: Oct 6, 2026, 4:00 PM EDT
TCMD
Tactile Systems Technology, Inc.
$22.19HealthcareDelayed quote: Oct 6, 2026, 4:00 PM EDT
Total return — CBIO vs TCMD
growth of $100 · dividends reinvested · last 10yCBIO -92.7% (-23.0%/yr)TCMD +18.1% (+1.7%/yr)TCMD compounded faster over this window
Log scale — wide-divergence pair
CBIO TCMD
CBIO vs TCMD: by the numbers
- •CBIO is the larger company ($504M vs $501M market cap).
- •TCMD is profitable (7.10% net margin) while CBIO runs a net loss (-1371.51%).
- •CBIO grew revenue faster over the past five years (39.89% vs 11.62% CAGR).
Metrics side by side
Valuation
| Metric | CBIO | TCMD |
|---|---|---|
| P/E ratio | N/A | 20.55 |
| Forward P/E | N/A | 19.87 |
| P/S ratio | 42.42 | 1.43 |
| P/B ratio | 3.17 | 2.24 |
| EV / EBITDA | N/A | 10.66 |
| FCF yield | N/A | 5.34% |
Profitability
| Metric | CBIO | TCMD |
|---|---|---|
| Gross margin | 100.00% | 74.23% |
| Operating margin | -1407.52% | 10.00% |
| Net margin | -1371.51% | 7.10% |
| ROE | -99.83% | 11.11% |
| ROIC | -102.59% | 9.54% |
Growth (annualized)
| Metric | CBIO | TCMD |
|---|---|---|
| Revenue CAGR (5Y) | 39.89% | 11.62% |
| FCF CAGR (5Y) | N/A | 32.09% |
| Total return CAGR (5Y) | -24.40% | -11.73% |
Frequently asked
- Which has grown faster, CBIO or TCMD?
- Over the past five years, CBIO grew revenue faster — CBIO at a 39.89% CAGR versus TCMD at 11.62%.
- Is CBIO or TCMD more profitable?
- TCMD runs the higher net margin — CBIO at -1371.51% versus TCMD at 7.10%.
- How have CBIO and TCMD total returns compared?
- Over the past 10 years, CBIO delivered -22.94% and TCMD delivered 1.68% annualized total return. Past performance doesn't predict future results.
Go deeper
Dig into the metrics
Tactile Systems Technology P/E ratioCrescent Biopharma ROETactile Systems Technology ROECrescent Biopharma operating marginTactile Systems Technology operating marginCrescent Biopharma revenue growthTactile Systems Technology revenue growthCrescent Biopharma free cash flowTactile Systems Technology free cash flow
Crescent Biopharma & Tactile Systems Technology appear in these rankings
Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified October 6, 2026.